OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Antibody All anti-DLEC1 antibodies

Anti-DLEC1 Antibody

div

Specifications Citations (0) Related Products Product Documents
SKU Description Amount Price Availability*  
TA314993 Rabbit polyclonal anti-DLEC1 antibody 100ul $325 3 Weeks
Add to Shopping Cart
spacer
IHC(1)
IF(1)

OriGene Data

ImmunogenThe antiserum was produced against synthesized peptide derived from N-terminal of human DLEC1.
Clone Name IsotypeIgG
Species ReactivityHuman (Identities = 100%, Positives = 100%) Concentration1mg/ml
Guaranteed Application *IHC, IF Suggested DilutionsIHC: 1:50~1:100, IF: 1:100~1:500, ELISA: 1:1000
BufferPhosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Purification The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Note DLEC1 antibody detects endogenous levels of total DLEC1 protein.

Reference Data

Target NameHomo sapiens deleted in lung and esophageal cancer 1 (DLEC1), transcript variant DLEC1-N1
Alternative NameCFAP81; DLC1; F56
Database LinkNP_031361
Entrez Gene 9940 Human
Function
Related Pathway

* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.

Immunohistochemistry analysis of paraffin-embedded human prostate carcinoma tissue, using DLEC1 antibody.The picture on the right is treated with the synthesized peptide.
spacer
Immunofluorescence analysis of HeLa cells, using DLEC1 antibody.The picture on the right is treated with the synthesized peptide.
spacer

 

spacer
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title